This week’s insights highlight three recent talking points in the world of medical communications
A new checklist for transparent AI use in scientific manuscripts
Researchers from the US have proposed a unified checklist to improve transparency around the use of generative artificial intelligence (genAI) in manuscript development.
The framework builds on existing guidance from organisations such as the International Committee of Medical Journal Editors (ICMJE), the Committee on Publication Ethics (COPE), and the World Association of Medical Editors (WAME). The checklist aims to help authors distinguish between acceptable and inappropriate uses of AI across linguistic and research-related tasks.
According to the authors, completing the checklist generates a standardised disclosure statement and a publicly accessible record of AI use linked to the manuscript.
What’s the real value of AI in MedComms?
A recent discussion at the 2026 European Meeting of the International Society for Medical Publication Professionals (ISMPP) MAP Newsletter explored the value of AI in medical communications. Speakers highlighted the potential of AI to strengthen scientific consistency, accelerate insights, expand access to patient-friendly content, and help teams manage evidence.
The discussion reinforced the importance of human oversight, selective implementation, and trust in scientific communications. A recurring message was that the value of AI is dependent on how effectively organisations balance quality, scalability, innovation, and responsible use.
Clinical Evaluation Reports: A growing opportunity for medical writers
A recent article from the American Medical Writers Association (AMWA) introduced Clinical Evaluation Reports (CERs), a regulatory requirement for medical devices seeking market access in Europe.
CERs involve the evaluation of clinical evidence to demonstrate the safety and performance of a device throughout its lifecycle. For medical writers, CERs represent a career pathway that combines literature reviews, data interpretation, regulatory knowledge, and scientific communication.
As regulatory requirements continue to evolve, demand for writers with expertise in CER development is expected to grow.
For more industry insights visit elion.nz/insights/
Want to get in touch? Contact us today at https://elion.nz/get-in-touch/
